scispace - formally typeset
K

Kari Alitalo

Researcher at University of Helsinki

Publications -  844
Citations -  122462

Kari Alitalo is an academic researcher from University of Helsinki. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor C. The author has an hindex of 174, co-authored 817 publications receiving 114231 citations. Previous affiliations of Kari Alitalo include Mount Sinai Hospital, Toronto & Cornell University.

Papers
More filters
Journal ArticleDOI

Blocking Angiopoietin-2 Promotes Vascular Damage and Growth Inhibition in Mouse Tumors Treated with Small Doses of Radiation

TL;DR: Combination treatment with anti-Ang2 and radiation improved tumor growth inhibition and extended the survival of mice with melanoma or colorectal tumors and Ang2 blocking rescued radiation-induced decreases in T cells and cells of the monocyte/macrophage lineage.
Journal ArticleDOI

Inside bloody lymphatics.

TL;DR: Lymphatic vessels were missed by many pathologists for centuries because they do not contain red blood cells, but the reason for this has been illuminated only now in several articles in Blood.
Journal ArticleDOI

Functional MRI Measurements to Predict Early Adenoviral Gene Therapy Response in Ovarian Cancer Mouse Model

TL;DR: Early changes in T2 relaxation times and ADC values after gene therapy suggest the potential of T1 relaxation time measurements and DW-MRI as early markers of treatment response after anti-angiogenic gene therapy and chemotherapy.
Book ChapterDOI

Five FGF receptors with distinct expression patterns.

TL;DR: The fibroblast growth factors (FGF) constitute a polypeptide family whose members can interact with cell surface receptors to modulate gene expression for cell proliferation and differentiation.
Journal ArticleDOI

Phase 1 Lymfactin® Study: 24-month Efficacy and Safety Results of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity Lymphedema.

TL;DR: Lymfactin® was combined with microvascular lymph node transfer surgery (VLNT) to study the safety and efficacy of the treatment in breast cancer-related upper limb lymphedema (BCRL) patients as mentioned in this paper .